Research Study for Children with Non-Alcoholic Fatty Liver Disease (NAFLD)
What is the purpose of this study?
Cincinnati Children’s is conducting a research
study, sometimes known as a clinical trial or clinical study, to evaluate
whether treatment with an investigational medication, cysteamine bitartrate
delayed release (DR), will help improve the livers of children diagnosed with
Nonalcoholic Fatty Liver Disease (NAFLD).
Who can participate?
Children and teens 8 to 17 years of age with
NAFLD will be eligible to participate. Participants must have a baseline biopsy
confirming a diagnosis of NAFLD and no history of poorly managed diabetes,
heart disease or other chronic liver diseases.
What is involved?
What is involved?
Participants will be randomly chosen to receive
either the study drug (cysteamine bitartrate DR) or a placebo (a substance that looks like the study drug but contains
no medication).
The treatment
part of the study lasts for approximately one year and post-treatment follow-up
lasts for approximately 24-weeks.
The following is a list of some of the procedures that will take place
during the study (in addition to regular clinic visits):
- Review
of medical history and current medications
- Check
of vital signs (blood pressure, heart rate, respiratory rate, body
temperature)
- Standardized lifestyle interventions (for example, strategies to reduce saturated fat and increase physical
activity)
- Blood draws
- Magnetic Resonance Imaging (MRI) scan
- End-of-treatment liver biopsy
What are the benefits?
Your child might not receive a direct medical
benefit. However, the information gained
from this study may
benefit individuals with NAFLD in the future.
Will I get all the facts about the study?
Parents
interested in having their child participate will be given a consent form that
thoroughly explains all of the details of the study. The form covers all of the
procedures, the risks, the benefits, the pay, who to contact with questions or
concerns and more. A member of the study staff will review the consent form
with you and will be sure that all of your questions are answered. Study
procedures will not begin until a parent or guardian has signed this form and,
if of age, the child has given at minimum his/her verbal agreement.
Do participants receive pay, compensation or reimbursement?
Participants will be paid up to $450,
in the form of gift cards, for completion of all study visits and procedures.
Who should I contact for more information?
Kimberlee Bernstein
kimberlee.bernstein@cchmc.org
513-636-4406
Steatohepatitis
Center
Division
of Gastroenterology, Hepatology and Nutrition
Cincinnati Children’s Hospital Medical Center, MLC
2010
3333 Burnet Ave.
Cincinnati, OH
45229-3039
Principal Investigator
Stavra Xanthakos, MD, MS
Steatohepatitis
Center
Division
of Gastroenterology, Hepatology and Nutrition
Cincinnati Children’s Hospital Medical Center
Co-Investigator:
Rohit
Kohli, MBBS, MS
Steatohepatitis
Center
Division
of Gastroenterology, Hepatology and Nutrition
Cincinnati Children’s Hospital Medical Center